Performance of the Monica Novii Wireless Patch System in Threatened and Actual Pre-Term Labour
1 other identifier
observational
31
1 country
1
Brief Summary
To study the equivalence of the Monica Novii™ Patch System in patients admitted for threatened pre-term labor and for pre-term labor \& delivery from 32 +0 weeks gestation by determining the equivalence of the Novii™ Patch System in monitoring Fetal Heart Rate (FHR), Maternal Heart Rate (MHR) and Uterine Contractions (UC) to Doppler FHR, tocodynamometer (TOCO) UC and photo plethysmograph MHR FDA approved predicates
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 2, 2016
CompletedFirst Submitted
Initial submission to the registry
May 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2017
CompletedFirst Posted
Study publicly available on registry
July 21, 2017
CompletedSeptember 23, 2019
September 1, 2019
11 months
May 4, 2017
September 20, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
FHR Deming Regression
Standard linear regression of y on x is not appropriate in this situation as the predicate device is not considered a gold standard, but as a device providing a measurement which may itself be subject to error, whereas the standard linear regression method assumes x to be measured without error. Deming regression is a method for calculating the regression line y=α+βx when both variables are subject to error, and the ratio of the error variances in x and y is known (and will be assumed to be equal to 1 in this analysis).
30min
Secondary Outcomes (7)
FHR Percent Agreement
30min
FHR Bland Altman
30min
MHR Percent agreement
30min
MHR bland altman
30min
UC percent agreement
30min
- +2 more secondary outcomes
Study Arms (1)
Pre Term and Threatened Pre-Term Labor
abdominal fetal/maternal monitoring
Interventions
A single passive patch placed on the abdomen that incorporates 5 electrodes and a monitoring device
Eligibility Criteria
Subjects admitted for threatened pre-term labor (total of 30 subjects) will be recruited for the study according to the following strata: - 15 patients with a gestation equal to 32 weeks +0 days gestation but \< 34 weeks +4 days - 5 patients with a Body Mass Index (BMI) less than 29 - 5 patients with a BMI equal to 29 but less than 35 - 5 patients with a BMI equal to or more than 35 - 15 patients with a gestation equal to 34 weeks +4 days gestation but \< 37 weeks +0 days - 5 patients with a BMI less than 29 - 5 patients with a BMI equal to 29 but less than 35 - 5 patients with a BMI equal to or more than 35. In addition, subjects admitted for pre-term labor \& delivery (total of 30 subjects) will be recruited. following the same stratification plan as above.
You may qualify if:
- She will require pre-term labor (at least 32 weeks 0 days gestation) monitoring with a singleton longitudinal, breech, transverse lie pregnancy.
You may not qualify if:
- The presence of any of the following factors or conditions would exclude the patient from consideration as a subject:
- Known major fetal malformation or chromosome abnormality.
- Multiple gestation
- A condition for which cesarean will likely be carried out shortly.
- Involvement in another clinical trial currently or previously in this pregnancy that, in the investigator's opinion, would affect the conduct of this study.
- Medical or obstetric problem that would preclude the use of abdominal electrodes (e.g., skin eruptions, history of sensitivity to adhesives).
- Parturient is under age 18.
- Medical or obstetric problem that in investigator's opinion would make the patient incapable of taking part in the study.
- Inability to understand the consent information due to medical illness or diminished intellectual capacity, or insurmountable language barrier.
- Potential for coercion, e.g. Prisoners.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ospedale dei Bambini Vittore Buzzi, Via Lodovico Castelvetro, 32
Milan, 20154, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Enrico Ferrazzi, Professor
l'Università degli Studi di Milano
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2017
First Posted
July 21, 2017
Study Start
July 2, 2016
Primary Completion
May 30, 2017
Study Completion
May 30, 2017
Last Updated
September 23, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share